Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Quek

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 10, 2018
Systematic review of current prognostication systems for primary gastrointestinal stromal tumorsChun Yuet Khoo, Xun Chai, Richard Quek, et al.
Asia-Pacific Journal of Clinical Oncology|December 14, 2011
Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: a case series and literature reviewJoen Chiang, Alexandre Chan, Tracy Lian, et al.
American Journal of Hematology|May 6, 2009
Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphomaGillianne Geet Yi Lai, Soon-Thye Lim, Miriam Tao, et al.
The Lancet. Oncology|November 2, 2013
Management of sarcoma in the Asia-Pacific region: resource-stratified guidelinesJeremy Lewin, Ajay Puri, Richard Quek, et al.
Advances in Hematology|January 15, 2011
Peripheral T-cell lymphoma: review and updates of current management strategiesTiffany Tang, Kevin Tay, Richard Quek, et al.
Clinical Sarcoma Research|August 13, 2020
Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysisMohamad Farid, Johnny Ong, Claramae Chia, et al.
Acta Medica Philippina|November 1, 2024
The Asian Sarcoma Consortium Sarcoma Preceptorship Program: A Program Evaluation Study Utilizing the Kirkpatrick Model (Level 1 and 2)Gracieux Y Fernando, Eileen Poon Yi Ling, Goh Wei Lin, et al.
Journal of Global Oncology|July 19, 2017
Cost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal TumorsGlorijoy Tan, Ke Zhou, Chee Hian Tan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 22, 2018
A response to the letter to the editor on "Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study"Denise Yeo, Ihtimam Hossain, Soon Thye Lim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2018
Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational studyDenise Yeo, Ihtimam Hossain, Soon Thye Lim, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 10, 2018
Systematic review of current prognostication systems for primary gastrointestinal stromal tumorsChun Yuet Khoo, Xun Chai, Richard Quek, et al.
Asia-Pacific Journal of Clinical Oncology|December 14, 2011
Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: a case series and literature reviewJoen Chiang, Alexandre Chan, Tracy Lian, et al.
American Journal of Hematology|May 6, 2009
Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphomaGillianne Geet Yi Lai, Soon-Thye Lim, Miriam Tao, et al.
The Lancet. Oncology|November 2, 2013
Management of sarcoma in the Asia-Pacific region: resource-stratified guidelinesJeremy Lewin, Ajay Puri, Richard Quek, et al.
Advances in Hematology|January 15, 2011
Peripheral T-cell lymphoma: review and updates of current management strategiesTiffany Tang, Kevin Tay, Richard Quek, et al.
Clinical Sarcoma Research|August 13, 2020
Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysisMohamad Farid, Johnny Ong, Claramae Chia, et al.
Acta Medica Philippina|November 1, 2024
The Asian Sarcoma Consortium Sarcoma Preceptorship Program: A Program Evaluation Study Utilizing the Kirkpatrick Model (Level 1 and 2)Gracieux Y Fernando, Eileen Poon Yi Ling, Goh Wei Lin, et al.
Journal of Global Oncology|July 19, 2017
Cost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal TumorsGlorijoy Tan, Ke Zhou, Chee Hian Tan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 22, 2018
A response to the letter to the editor on "Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study"Denise Yeo, Ihtimam Hossain, Soon Thye Lim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2018
Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational studyDenise Yeo, Ihtimam Hossain, Soon Thye Lim, et al.
Pageof 8